Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 59576 - 59600 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Piroxicam	Approved Investigational	XPOT	11260	downregulated	Piroxicam results in decreased expression of XPOT mRNA	12q14.2	A23661
Piroxicam	Approved Investigational	YWHAB	7529	upregulated	Piroxicam results in increased expression of YWHAB mRNA	20q13.12	A23661
Piroxicam	Approved Investigational	ZMPSTE24	10269	downregulated	Piroxicam results in decreased expression of ZMPSTE24 mRNA	1p34.2	A23661
Piroxicam	Approved Investigational	ZMYND8	23613	downregulated	Piroxicam results in decreased expression of ZMYND8 mRNA	20q13.12	A23661
Piroxicam	Approved Investigational	ZNF207	7756	downregulated	Piroxicam results in decreased expression of ZNF207 mRNA	17q11.2	A23661
Piroxicam	Approved Investigational	ZWILCH	55055	upregulated	Piroxicam results in increased expression of ZWILCH mRNA	15q22.31	A23661
Piroxicam	Approved Investigational	ZWINT	11130	downregulated	Piroxicam results in decreased expression of ZWINT mRNA	10q21-q22	A23661
Pitavastatin	Approved Investigational	ABCA1	19	upregulated	pitavastatin results in increased expression of ABCA1 mRNA	9q31.1	A20979
Pitavastatin	Approved Investigational	PON1	5444	upregulated	pitavastatin results in increased expression of PON1 mRNA	7q21.3	A20977
Pitavastatin	Approved Investigational	PPARA	5465	upregulated	pitavastatin results in increased expression of PPARA mRNA	22q13.31	A20979
Pitavastatin	Approved Investigational	PPARD	5467	upregulated	pitavastatin results in increased expression of PPARD mRNA	6p21.31	A20979
Platelet Activating Factor	Experimental	AGTR1	185	upregulated	Platelet Activating Factor results in increased expression of AGTR1 mRNA	3q24	A19846
Platelet Activating Factor	Experimental	ALOX12	239	upregulated	Platelet Activating Factor results in increased expression of ALOX12 mRNA	17p13.1	A19846
Platelet Activating Factor	Experimental	ALOX5	240	upregulated	Platelet Activating Factor results in increased expression of ALOX5 mRNA	10q11.21	A19846
Platelet Activating Factor	Experimental	CCR2	729230	upregulated	Platelet Activating Factor results in increased expression of CCR2 mRNA	3p21.31	A19846
Platelet Activating Factor	Experimental	CRP	1401	upregulated	Platelet Activating Factor results in increased expression of CRP mRNA	1q23.2	A19846
Platelet Activating Factor	Experimental	CX3CR1	1524	upregulated	Platelet Activating Factor results in increased expression of CX3CR1 mRNA	3p22.2	A19846
Platelet Activating Factor	Experimental	EGR1	1958	upregulated	Platelet Activating Factor results in increased expression of EGR1 mRNA	5q31.2	A19846
Platelet Activating Factor	Experimental	IL1A	3552	upregulated	Platelet Activating Factor results in increased expression of IL1A mRNA	2q14.1	A19846
Platelet Activating Factor	Experimental	IL1B	3553	upregulated	Platelet Activating Factor results in increased expression of IL1B mRNA	2q14.1	A19846
Platelet Activating Factor	Experimental	MMP13	4322	upregulated	Platelet Activating Factor results in increased expression of MMP13 mRNA	11q22.2	A19846
Platelet Activating Factor	Experimental	OLR1	4973	upregulated	Platelet Activating Factor results in increased expression of OLR1 mRNA	12p13.2	A19846
Platelet Activating Factor	Experimental	PLA2G7	7941	upregulated	Platelet Activating Factor results in increased expression of PLA2G7 mRNA	6p12.3	A23662
Platelet Activating Factor	Experimental	PPARA	5465	downregulated	Platelet Activating Factor results in decreased expression of PPARA mRNA	22q13.31	A19846
Platelet Activating Factor	Experimental	PTAFR	5724	upregulated	Platelet Activating Factor results in increased expression of PTAFR mRNA	1p35.3	A19846

Displaying entries 59576 - 59600 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability